Immunovia AB (publ) – LSE:0G8X.L
Immunovia AB (publ) stock price today
Immunovia AB (publ) stock price monthly change
Immunovia AB (publ) stock price quarterly change
Immunovia AB (publ) stock price yearly change
Immunovia AB (publ) key metrics
Market Cap | 111.50M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -6.05 |
Revenue | 1.21M |
EBITDA | -123.79M |
Income | -260.72M |
Revenue Q/Q | -70% |
Revenue Y/Y | -18.27% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -10214.36% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeImmunovia AB (publ) stock price history
Immunovia AB (publ) stock forecast
Immunovia AB (publ) financial statements
| Jun 2023 | 412K | -170.20M | -41311.89% |
|---|---|---|---|
| Sep 2023 | 488K | -38.55M | -7900.82% |
| Dec 2023 | 156K | -49.02M | -31423.08% |
| Mar 2024 | 156K | -2.94M | -1888.46% |
| Jun 2023 | 190103000 | 58.83M | 30.95% |
|---|---|---|---|
| Sep 2023 | 149594000 | 56.37M | 37.68% |
| Dec 2023 | 98681000 | 31.69M | 32.11% |
| Mar 2024 | 71024000 | 27.32M | 38.48% |
| Jun 2023 | -43.29M | -1.04M | 119.61M |
|---|---|---|---|
| Sep 2023 | -35.56M | 39K | -1.66M |
| Dec 2023 | -28.48M | 711K | -1.64M |
| Mar 2024 | -24.42M | 0 | -1.53M |
Immunovia AB (publ) alternative data
| Aug 2023 | 51 |
|---|---|
| Sep 2023 | 51 |
| Oct 2023 | 39 |
| Nov 2023 | 39 |
| Dec 2023 | 25 |
| Jan 2024 | 25 |
| Feb 2024 | 25 |
| Apr 2024 | 11 |
| May 2024 | 11 |
| Jun 2024 | 11 |
| Jul 2024 | 11 |
Immunovia AB (publ) other data
-
What's the price of Immunovia AB (publ) stock today?
One share of Immunovia AB (publ) stock can currently be purchased for approximately $25.22.
-
When is Immunovia AB (publ)'s next earnings date?
Unfortunately, Immunovia AB (publ)'s (0G8X.L) next earnings date is currently unknown.
-
Does Immunovia AB (publ) pay dividends?
No, Immunovia AB (publ) does not pay dividends.
-
How much money does Immunovia AB (publ) make?
Immunovia AB (publ) has a market capitalization of 111.50M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 37.55% to 1.58M US dollars.
-
What is Immunovia AB (publ)'s stock symbol?
Immunovia AB (publ) is traded on the LSE under the ticker symbol "0G8X.L".
-
What is Immunovia AB (publ)'s primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Immunovia AB (publ)?
Shares of Immunovia AB (publ) can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Immunovia AB (publ) have?
As Jul 2024, Immunovia AB (publ) employs 11 workers.
-
When Immunovia AB (publ) went public?
Immunovia AB (publ) is publicly traded company for more then 7 years since IPO on 26 Jan 2018.
-
What is Immunovia AB (publ)'s official website?
The official website for Immunovia AB (publ) is immunovia.com.
-
How can i contact Immunovia AB (publ)?
Immunovia AB (publ) can be reached via phone at +46 46 275 60 00.
Immunovia AB (publ) company profile:
Immunovia AB (publ)
immunovia.comLSE
10
Medical - Diagnostics & Research
Healthcare
Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Lund, 223 63
:
ISIN: SE0006091997
:
